Search Results 2581-2590 of 25646 for oral

  1. Dust mite allergy - Symptoms & causes - Mayo Clinic

    Many people with dust mite allergy also experience signs of asthma, such as wheezing and difficulty breathing. Dust mites, close relatives of ticks and spiders, ...

  2. Molecular Analysis of Esophageal Samples Using a Minimally Invasive Collection Device - Mayo Clinic

    Patients on oral thrombin inhibitors including Dabigatran and oral factor X a inhibitors such as rivaroxaban, apixaban and edoxaban, unless discontinued for ...

  3. Bromfenac (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Bromfenac ophthalmic (eye) solution is used to treat pain or swelling of the eye following cataract surgery. This medicine is a topical nonsteroidal anti- ...

  4. Fulvestrant (intramuscular route) - Mayo Clinic

    Fulvestrant injection is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in ...

  5. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

    Patients must have pathologically confirmed, previously untreated, unresected squamous cell carcinoma of the larynx, hypopharynx, oropharynx, oral cavity ...

  6. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Oral 5-aminosalicylate (5-ASA); Oral corticosteroid therapy; Antidiarrheals for chronic diarrhea; Azathioprine or 6-mercaptopurine (6-MP) or methotrexate ...

  7. A First in Man Trial for Patients With Cancer - Mayo Clinic

    Inability to swallow oral meds or gastrointestinal disorder that might interfere with absorption of oral drugs; Major surgery within 28 days of first receipt ...

  8. Fecal Microbiota Clinical Trials - Mayo Clinic Research

    ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

  9. Fecal Microbiota (Stool Clinical Trials - Mayo Clinic Research

    ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

  10. A Study to Evaluate the Safety and Effectiveness of NX9 for CT Imaging in Patients with Cancer or GI Disease - Mayo Clinic

    The purpose of this study is to collect safety, effectiveness and pharmacokinetics (in a subgroup of subjects) data on the use of NX9 as an oral CT contrast ...